A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia

Clinical trial NCT04896112 · WITHDRAWN

Trial details

NCT number: NCT04896112
Sponsor: Lynk Pharmaceuticals Co., Ltd
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis Polycythemia Vera

Start date: 2021-04-08
Primary completion: 2022-10-20
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.